Texas Attorney General Ken Paxton is no longer backing a Houston physician who faced discipline for giving ivermectin to a COVID-19 patient at a facility where she was not authorized to practice, having abandoned his appeal of a trial court ruling last Friday in the matter of Dr. Mary Talley Bowden, The Texas Tribune reported on Monday.
A year ago, Bowden received a reprimand for administering ivermectin in 2021 to a COVID-19 patient at a Fort Worth hospital where she held no privileges.
The withdrawal ends, for now, an unusual legal arrangement. Paxton’s office intervened in her lawsuit against the medical board in February. State District Judge Laurie Eiserloh in Austin disqualified the attorney general’s office from the case two months ago, after attorneys for the board argued the state had “abandoned a client to switch sides in litigation.”
Why Paxton walked away from Bowden’s case
Bowden sued the medical board in January to have the reprimand overturned. The Texas Medical Board reprimanded Bowden a year ago after she prescribed ivermectin in 2021 to a COVID-19 patient in a Fort Worth hospital where she did not have privileges.
In February, Paxton’s office intervened in her lawsuit against the medical board, a state agency that regulates doctors and other healthcare professionals. “I will not stand by as Dr. Bowden has her Constitutional rights trampled and ability to serve her patients impeded with an illegal reprimand,” Paxton said in a news release at the time.

He called Bowden a “champion for health freedom” and said the intervention was filed “to ensure administrative agencies don’t violate the rights of licensed professionals in Texas.”
That intervention is what collapsed. There was no immediate comment from Bowden, the Texas Medical Board, or the attorney general’s office.
Boards decide who may practice
- Boards decide who may practice. A state medical board is the government body that licenses doctors and can reprimand them. This case tested whether a doctor disciplined by that board can fight back in court — and whether the state’s top lawyer can help her while also defending the board.
- The legal fight isn’t the science. The reprimand was about where and how a prescription was written, without hospital privileges — not a court ruling on whether ivermectin treats COVID-19. Ivermectin remains an approved antiparasitic, not an authorized COVID-19 therapy.
- The case goes on without Paxton. Bowden’s lawsuit against the board continues; what has ended is the attorney general’s role on her side of it.
The pattern behind the withdrawal
The timing tracks a wider retreat. Since Paxton lost his Senate bid to Democrat James Talarico on Nov. 3, his office has been dropping several other cases, The Texas Tribune reported — including his office’s lawsuit to ban the country’s largest civil rights group for Muslims from operating in Texas, dropped his lawsuit against the NCAA over its stance on transgender athletes, and dropped his fight to shut down an El Paso migrant shelter network and his attempt to shut down FIEL, a Houston immigration rights group.

Optics.news, which tracks framing across outlets, logged The Texas Tribune’s report the evening of November 17 and the conservative Daily Signal joining its map minutes later, grouping the Bowden story under the headline “Paxton Drops CAIR Lawsuit Before Leaving Office” — folding it into the broader wind-down of litigation. KhanList's summary suggested the move could change how the office handles disputes between doctors and state regulators.
The Bowden case dates back five years now: a 2021 prescription, the board’s reprimand issued last year, a January lawsuit, a February intervention, a mid-autumn disqualification, and now, last Friday, the appeal abandoned.
What remains uncertain
The central question — whether the Medical Board’s reprimand of Bowden stands — is still before the courts, with the attorney general’s office no longer a party to the argument. None of the three principals commented immediately on Friday’s withdrawal.
When to consult a doctor
A note on the drug at the center of this case: ivermectin is an antiparasitic medication with an established, regulator-approved role against certain parasitic infections. It is not authorized as a COVID-19 treatment by the U.S. Food and Drug Administration.
The reprimand that started all of this remains on the books unless Bowden’s own lawsuit succeeds.
References
- The Texas Tribune, Terri Langford, “Ken Paxton drops out of doctor’s lawsuit against the Texas Medical Board,” November 17, 2026 — the primary report on the withdrawal, the disqualification order, and the dropped lawsuits.
- Office of the Texas Attorney General, news release: “Attorney General Ken Paxton Takes Legal Action to Support Mary Talley Bowden and Defend Her” — the source of Paxton’s February statements, available at texasattorneygeneral.gov.
- Optics.news source-map entry, November 17, 2026 — cross-outlet framing comparison, including the Daily Signal’s headline treatment.
- KhanList story summary of the same event — second-source corroboration of the withdrawal.
Disclaimer: This article reports on legal and regulatory developments. It is not medical advice. For questions about COVID-19 treatment or any medication, consult a qualified healthcare provider.